Citius Pharmaceuticals Inc. (CTXR) NASDAQ
$0.72 (0.05) (-6.62%)
Market Cap: $122.07M
As of 04/24/24 04:00 PM EDT. Market closed.
Citius Pharmaceuticals Inc. (CTXR)
NASDAQ
$0.72
(0.05) (-6.62%)
Market Cap: $122.07M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
citius pharmaceuticals, inc., a specialty pharmaceutical company, develops and commercializes critical care products. it primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. the company is developing mino-lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Myron Holubiak
Full Time Employees
16
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Myron Holubiak
Full Time Employees
16
Address
11 Commerce Dr Fl 1, New Jersey, Cranford, 07016-3501.
PRICE CHART FOR CITIUS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.77
Previous Close
$0.77
Days Range
$0.70 - $0.77
52 week range
$0.60 - $1.56
Volume
877,958
Avg. Volume (30 days)
1,255,398
Market Cap
$122.07M
Dividend Yield
-
P/E
-
Shares Outstanding
159,094,781
Open
$0.77
Previous Close
$0.77
Days Range
$0.70 - $0.77
52 week range
$0.60 - $1.56
Volume
877,958
Avg. Volume (30 days)
1,255,398
Market Cap
$122.07M
Dividend Yield
-
P/E
-
Shares Outstanding
159,094,781
FINANCIAL STATEMENTS FOR CITIUS PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CITIUS PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Mazur Leonard L | Executive Chairman | Sep 27, 2019 | Buy | $0.90 | 2,234,700 | 2,000,280 | 10,255,343 | Sep 27, 2019, 04:16 PM |
| HOLUBIAK MYRON Z | President and CEO | Sep 27, 2019 | Buy | $0.90 | 558,597 | 500,000 | 1,992,243 | Sep 27, 2019, 04:15 PM |
| Mazur Leonard L | Executive Chairman | Apr 03, 2019 | Buy | $1.54 | 1,165,048 | 1,799,999 | 8,020,643 | Apr 05, 2019, 04:06 PM |
| HOLUBIAK MYRON Z | President and CEO | Apr 03, 2019 | Buy | $1.54 | 129,450 | 200,000 | 1,433,646 | Apr 05, 2019, 04:06 PM |
| Mazur Leonard L | Executive Chairman | Aug 13, 2018 | Buy | $1.27 | 3,137,255 | 4,000,000 | 6,855,595 | Aug 15, 2018, 05:07 PM |
| HOLUBIAK MYRON Z | President and CEO | Aug 13, 2018 | Buy | $1.27 | 784,314 | 1,000,000 | 1,304,196 | Aug 15, 2018, 05:06 PM |
| Mazur Leonard L | Executive Chairman | Mar 29, 2018 | Buy | $2.98 | 167,504 | 499,999 | 3,718,340 | Apr 02, 2018, 03:56 PM |
| HOLUBIAK MYRON Z | President and CEO | Mar 28, 2018 | Buy | $3.09 | 2,915 | 9,007 | 519,882 | Mar 29, 2018, 06:00 PM |
| Mazur Leonard L | Executive Chairman | Dec 19, 2017 | Buy | $4.69 | 213,106 | 999,467 | 3,550,836 | Jan 08, 2018, 04:05 PM |
| Mazur Leonard L | Executive Chairman | Aug 24, 2017 | Buy | $2.68 | 11,000 | 29,480 | 3,337,730 | Aug 28, 2017, 09:07 PM |
| Mazur Leonard L | Executive Chairman | Aug 08, 2017 | Option Exercise | $3.09 | 1,547,067 | 4,780,437 | 3,326,730 | Aug 10, 2017, 06:07 PM |
| Mazur Leonard L | Executive Chairman | Aug 08, 2017 | Buy | $4.13 | 421,400 | 1,738,275 | 1,779,663 | Aug 10, 2017, 06:07 PM |
| Mazur Leonard L | Director | Mar 30, 2016 | Buy | $0.60 | 5,000,000 | 3,000,000 | 5,457,143 | Apr 12, 2016, 05:17 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Mazur Leonard L | Executive Chairman | 09/27/2019 | 2,000,280 |
| HOLUBIAK MYRON Z | President and CEO | 09/27/2019 | 500,000 |
| Mazur Leonard L | Executive Chairman | 04/03/2019 | 1,799,999 |
| HOLUBIAK MYRON Z | President and CEO | 04/03/2019 | 200,000 |
| Mazur Leonard L | Executive Chairman | 08/13/2018 | 4,000,000 |
| HOLUBIAK MYRON Z | President and CEO | 08/13/2018 | 1,000,000 |
| Mazur Leonard L | Executive Chairman | 03/29/2018 | 499,999 |
| HOLUBIAK MYRON Z | President and CEO | 03/28/2018 | 9,007 |
| Mazur Leonard L | Executive Chairman | 12/19/2017 | 999,467 |
| Mazur Leonard L | Executive Chairman | 08/24/2017 | 29,480 |
| Mazur Leonard L | Executive Chairman | 08/08/2017 | 4,780,437 |
| Mazur Leonard L | Executive Chairman | 08/08/2017 | 1,738,275 |
| Mazur Leonard L | Director | 03/30/2016 | 3,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CITIUS PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 8,457,814 | 0.00016% | 8.63% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 2,779,908 | 0.00022% | 3.91% | Other |
CHANGE IN SHARES OUTSTANDING FOR CITIUS PHARMACEUTICALS INC
STOCK BUYBACKS FOR CITIUS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.01%
1Q
06/30/2023
3.37%
2Q
03/31/2023
8.69%
3Q
12/31/2022
8.72%
4Q
09/30/2022
8.76%
5Q
06/30/2022
8.78%
6Q
03/31/2022
8.84%
7Q
12/31/2021
8.86%
8Q
09/30/2021
46.37%
9Q
06/30/2021
15.90%
10Q
03/31/2021
65.58%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CITIUS PHARMACEUTICALS INC
LOADING...